Antidepressants in long-term therapy: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors

Keyphrases

• Long-term Treatment 100%
• Selective Serotonin Reuptake Inhibitors 100%
• Antidepressants 100%
• Tricyclic Antidepressants 100%
• Continuation Treatment 40%
• Depressed Patients 40%
• Maintenance Studies 40%
• Illness 20%
• Placebo 20%
• Depression Treatment 20%
• Patients at Risk 20%
• Remission 20%
• Maintenance Therapy 20%
• Acute Response 20%
• Prospective Randomized Trial 20%
• New Agents 20%
• Tolerability 20%
• Recurrence Rate 20%
• Acute Treatment 20%
• Active Treatment 20%
• Continuation Therapy 20%
• Randomized Design 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Selective Serotonin Reuptake Inhibitor 100%
• Antidepressant 100%
• Tricyclic Antidepressant 100%
• Diseases 66%
• Placebo 33%
• Recurrent Disease 33%
• Recurrence Risk 33%
• Remission 33%
• Tolerability 33%

Neuroscience

• Selective Serotonin Reuptake Inhibitor 100%
• Antidepressant 100%
• Tricyclic Antidepressant 100%
• Placebo 33%
• Treatment of Depression 33%